The approval gives Ozempic (semaglutide) the broadest label in the class, coming after earlier approvals for type 2 diabetes itself and cardiovascular risk reduction in diabetics with known heart disease
Our CLP model showed chronic Nrf2/HO-1/GPX4 suppression (day 7) linked to GSH depletion, ferroptosis, and irreversible antioxidant collapse (Xie et al., 2020), supporting Nrf2 activators (e.g., sulforaphane) or GSH precursors (e.g., NAC) as interventions (Yusri et al., 2025)
Secondly, supplement compliance is a potential limitation
Rotating your injection sites is critical to preventing lipodystrophya condition where repeated injections cause fat tissue breakdown or thickening at the injection site
Payers expect specificity
Mechanisms of ADA Formation ADAs are typically formed when the immune system recognizes the receptor agonists as a foreign entity